policy
FMR LLC Sells $10.04 Million in Beam Therapeutics Shares
FMR LLC sold $10.04 million in Beam Therapeutics shares, according to Investing.com, putting institutional positioning in focus for investors.
Tyrian Trade Market News
BEAM news and market updates
Latest BEAM news, market updates, and related coverage from Tyrian Trade.
Categories
Latest news
tech
Beam Therapeutics Rating Downgrade Signals Caution for Investors
Beam Therapeutics faces a rating downgrade as analysts suggest a better entry point may emerge, raising questions for biotech investors.